Serum lipid-bound sialic acid in lung cancer patients
Chinese Journal of Cancer Research(1995)
摘要
Serum lipid-bound sialic acid (LSA) assay was evaluated for differential diagnosis between benign and malignant pulmonary
disease. Mean serum LSA for normal controls was 13.7±3.7 mg/dl and the upper limit of the normal value was set at 19.8 mg/dl
(95% confidence limit, one side). The specificity was 97.1% (95% confidence interval was 93.8%, 100.0%). The mean for benign
pulmonary disease was 17.1±5.1 mg/dl, the specificity was 89.1% (95% confidence interval was 80.9%, 97.3%), and the sensitivity
was 10.9%. The mean for malignant pulmonary disease was 27.1±7.9 mg/dl, and the sensitivity was 93.3% (95% confidence interval
was 88.5%, 98.1%). The serum LSA levels for different malignant pulmonary diseases were different between small cell carcinoma
and adenocarcinoma. The results indicate that serum LSA assay might be used as tumor marker to differentiate lung cancer from
normal subjects or benign lung disease.
更多查看译文
关键词
lung cancer,resorcinoi-hcl.,serum,lipid-bound sialic acid,serum lipids,confidence limit,confidence interval
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要